Interventions
ASCOT is currently trialling the following treatment approach, called a ‘domain’.
- Domain A: Antiviral Drugs – to stop the virus from multiplying
- Remdesivir
- Paxlovid (Nirmatrelvir-Ritonavir)
- Remdesivir
- Remdesivir is a medicine used to help people who are sick with certain viruses, including the one that causes COVID-19.
- Remdesivir works by interfering with the virus's ability to make copies of itself. This can help slow down the virus's spread in the body and give the immune system more time to fight it off.
- Remdesivir is given intravenously through a drip, once a day, for 5 days or until you leave hospital.
- Paxlovid
- Paxlovid (Nirmatrelvir-ritonavir) is a combination of two different drugs that work together to fight viruses.
- Nirmatrelvir is like a blocker that stops the virus from getting into our cells. Ritonavir helps to make sure that nirmatrelvir stays in the body longer, so it can keep working to stop the virus entering our cells.
- Nirmatrelvir-ritonavir is given as an oral tablet for 5 days.
The tables below outline the possible side effects for each treatment and how likely they are to occur.
Common (>10%) |
More than 10 people out of every 100 people will report this side effect |
Uncommon (1-10%) |
1 to 10 people out of every 100 people will report this side effect |
Rare (0.1-1%) |
1 in 1,000 to 1 in 100 people will report this side effect |
Very Rare (<0.1%) |
less than 1 in 1,000 people will report this side effect |
Domain A – Antiviral Drugs |
|||||||||||||||||||||
Remdesivir |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||
Nirmatrelvir-Ritonavir (Paxlovid) |
|||||||||||||||||||||
|